Industry evening symposium
Integrating Type 2 Biologics in the Management of Uncontrolled Severe Asthma: The Importance of Lung Function in Disease Control
Organized by : Sanofi Genzyme and Regeneron Pharmaceuticals
17:15
Welcome and Introduction
K. Rabe (Kiel, Germany)
1
3451
17:25
Impaired lung function: What does it mean for the patient?
M. Humbert (Le Kremlin-Bicêtre, France)
2
3452
17:55
Unravelling type 2 inflammation and its role in lung physiology
K. Rabe (Kiel, Germany)
3
3453
18:25
Targeted strategies for improving lung function in the management of severe asthma
M. Wechsler (Denver, United States)
4
3454
19:00
Panel Q&A and Closing Remarks
K. Rabe (Kiel, Germany)
5
3455
. . .
